These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18261946)

  • 1. [The Oxygen effect: an old new target?].
    Lartigau E; Dewas S; Gras L
    Cancer Radiother; 2008 Jan; 12(1):42-9. PubMed ID: 18261946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical radiosensitizers for use in radiotherapy.
    Wardman P
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AQ4N: a new approach to hypoxia-activated cancer chemotherapy.
    Patterson LH; McKeown SR
    Br J Cancer; 2000 Dec; 83(12):1589-93. PubMed ID: 11104551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New radiosensitizing regimens, drugs, prodrugs, and candidates.
    Vallerga AK; Zarling DA; Kinsella TJ
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a therapeutic gain when AQ4N or tirapazamine is combined with radiation.
    McKeown SR; Friery OP; McIntyre IA; Hejmadi MV; Patterson LH; Hirst DG
    Br J Cancer Suppl; 1996 Jul; 27():S39-42. PubMed ID: 8763843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis and radiotherapy (vessels, anaemia, oxygen and radiosensitivity)].
    Lartigau E
    Bull Cancer; 2007 Jul; 94 Spec No():S197-202. PubMed ID: 17846005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
    De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
    Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments.
    Hoogsteen IJ; Marres HA; van der Kogel AJ; Kaanders JH
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):385-96. PubMed ID: 17433637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
    Saunders M; Dische S
    Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor hypoxia in cancer therapy.
    Brown JM
    Methods Enzymol; 2007; 435():297-321. PubMed ID: 17998060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide.
    Xueguan L; Xiaoshen W; Yongsheng Z; Chaosu H; Chunying S; Yan F
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):606-12. PubMed ID: 18692368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamine.
    Hicks KO; Myint H; Patterson AV; Pruijn FB; Siim BG; Patel K; Wilson WR
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):560-71. PubMed ID: 17869669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anemia and radiotherapy].
    Pasquier D; Lartigau E
    Bull Cancer; 2003 Apr; 90 Spec No():S152-7. PubMed ID: 12856427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical studies of hypoxia modification in radiotherapy.
    Kaanders JH; Bussink J; van der Kogel AJ
    Semin Radiat Oncol; 2004 Jul; 14(3):233-40. PubMed ID: 15254866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical applications of high-pressure oxygen and radiosensitizing agents in radiotherapy].
    Egawa J
    Gan No Rinsho; 1967 Aug; 13(8):606-16. PubMed ID: 4868595
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation sensitization with redox modulators: a promising approach.
    Rosenberg A; Knox S
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):343-54. PubMed ID: 16414370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies.
    Magagnin MG; Koritzinsky M; Wouters BG
    Drug Resist Updat; 2006; 9(4-5):185-97. PubMed ID: 16926105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia: targeting the tumour.
    Boyle RG; Travers S
    Anticancer Agents Med Chem; 2006 Jul; 6(4):281-6. PubMed ID: 16842231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioreductive therapy.
    Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1992; 22(4):685-7. PubMed ID: 1544837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.